Helong Zhao1, Tasha Wilkie2, Yadwinder Deol3, Amita Sneh4, Akaansha Ganju5, Mustafa Basree6, Mohd W Nasser7, Ramesh K Ganju8. 1. Department of Pathology, The Ohio State University Wexner Medical Center, 840 BRT, 460 W 12th Ave, Columbus, 43210, OH, USA. zhao.364@osu.edu. 2. Department of Pathology, The Ohio State University Wexner Medical Center, 840 BRT, 460 W 12th Ave, Columbus, 43210, OH, USA. wilkie.20@osu.edu. 3. Department of Pathology, The Ohio State University Wexner Medical Center, 840 BRT, 460 W 12th Ave, Columbus, 43210, OH, USA. yadwinder.deol@osumc.edu. 4. Department of Pathology, The Ohio State University Wexner Medical Center, 840 BRT, 460 W 12th Ave, Columbus, 43210, OH, USA. amita.sneh@osumc.edu. 5. Department of Pathology, The Ohio State University Wexner Medical Center, 840 BRT, 460 W 12th Ave, Columbus, 43210, OH, USA. akaansha.ganju@osumc.edu. 6. Department of Pathology, The Ohio State University Wexner Medical Center, 840 BRT, 460 W 12th Ave, Columbus, 43210, OH, USA. basree.1@osu.edu. 7. Department of Pathology, The Ohio State University Wexner Medical Center, 840 BRT, 460 W 12th Ave, Columbus, 43210, OH, USA. Mohd.Nasser@osumc.edu. 8. Department of Pathology, The Ohio State University Wexner Medical Center, 840 BRT, 460 W 12th Ave, Columbus, 43210, OH, USA. Ramesh.Ganju@osumc.edu.
ErratumAfter publication of [1] it came to the authors’ attention that in the abstract. The sentence “In the present study, we show that S100A7 significantly downregulates the expression of miR-29b in Estrogen Receptor (ER)-positive breast cancer cells (represented by MCF7), and significantly upregulates miR-29b in ER-negative cells (represented by MDA-MB-231)”. Was Incorrect, the correct statement is “In the present study, we show that S100A7 significantly upregulates the expression of miR-29b in Estrogen Receptor (ER)-positive breast cancer cells (represented by MCF7), and significantly downregulates miR-29b in ER-negative cells (represented by MDA-MB-231)”.